Study of Latiglutenase in T1D/CD Patients

NCT04839575 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Covid-19 interruptions and enrollment challenges

Conditions

Celiac Disease

Interventions

DRUG: Latiglutenase
DRUG: Placebo

Sponsor

Entero Therapeutics

Collaborators

[object Object]
[object Object]